Qian Chen

Qian Chen

Auto-generated profile, based on publicly available information

Qian Chen

Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Clinical Research Center for Oral Diseases of Zhejiang Province, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2020 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
QCQian Chen
Qian Chen
SSShaojuan Song
Shaojuan Song
ZWZhen Wang
Zhen Wang
YSYingqiang Shen
Yingqiang Shen
LXLiang Xie
Liang Xie
QCQianming Chen
Qianming Chen

12 August 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CXChangqing Xie
Changqing Xie
ZLZaiye Li
Zaiye Li
YHYufei Hua
Yufei Hua
SSSilu Sun
Silu Sun
LZLiang Zhong
Liang Zhong
QCQianming Chen
Qianming Chen
Oral submucous fibrosis (OSF) is a chronic and insidious oral potentially malignant disorder associated with a 4–17% risk of oral squamous cell carcinoma (OSCC). Our previous study found that proteasomal activator 28 gamma (PA28γ) is frequently overexpressed in oral squamous cell carcinoma and negatively correlated with poor patient prognosis. However, the role of PA28γ in the occurrence and development of OSF remains unclear. Here, we screened PA28γ-related genes and investigated their function in OSF. We demonstrated that the expression of PA28γ was positively associated with MEK1 and gradually elevated from normal to progressive stages of OSF tissue. Arecoline, a pathogenic component of OSF, could upregulate the protein levels of PA28γ and phosphorylated MEK1 and contribute to epithelial to mesenchymal transition (EMT) in epithelial cells. Notably, PA28γ could interact with MEK1 and upregulate its phosphorylation level. Furthermore, arecoline upregulated BRAF, which can interact with PA28γ and upregulate its protein level. Additionally, BRAF, PA28γ, and MEK1 could form protein complexes and then enhance the MEK1/ERK signaling pathways. The concrete mechanism of the protein stability of PA28γ is that BRAF mediates its degradation by inhibiting its ubiquitination. These findings underscore the instrumental role of PA28γ in the BRAF/MEK1 pathway and enhanced EMT through MEK1/ERK activation in OSF.

6 September 2019 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
Sameul ZhangSameul Zhang
Sameul Zhang
HMHongdao Meng
Hongdao Meng
QCQian Chen
Qian Chen
XWXiaoling Wang
Xiaoling Wang
JZJiatong Zou
Jiatong Zou
JWJinhui Wu
Jinhui Wu

2 February 2021 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
FYFengying Yin
Fengying Yin
QCQian Chen
Qian Chen
YSYujie Shi
Yujie Shi
HXHao Xu
Hao Xu
JHJie Huang
Jie Huang
XZXin Zeng
Xin Zeng

30 September 2022 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
QCQian Chen
Qian Chen
ZWZuPing Wu
ZuPing Wu
LXLiang Xie
Liang Xie

31 January 2024 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
QCQian Chen
Qian Chen
ZWZuPing Wu
ZuPing Wu
YSYuJie Shi
YuJie Shi
ZLZaiYe Li
ZaiYe Li
JYJiaKang Yang
JiaKang Yang
QCQianming Chen
Qianming Chen
Proteasome activator subunit 3 (PA28γ) is a member of the proteasome activator family, which mainly regulates the degradation and stability of proteins. Studies have shown that it plays crucial roles in lipid formation, stemness maintenance, and blood vessel formation. However, few studies have clarified the association between PA28γ and bone diseases. Herein, we identified PA28γ as a previously unknown regulator of bone homeostasis that coordinates bone formation and lipid accumulation. PA28γ-knockout mice presented with the characteristics of low bone mass and accumulation of lipids. Suppressed expression of PA28γ restrained the osteogenic differentiation and enhanced the adipogenic differentiation of bone marrow stromal cells (BMSCs). Overexpression of PA28γ promoted osteogenic differentiation and inhibited adipogenic differentiation of BMSCs. Mechanistically, PA28γ interacted with Wnt5α, and the two interactors appeared to be positively correlated. PA28γ mainly activated the downstream Wnt/β-catenin signaling pathway, which affects BMSCs differentiation homeostasis. Deletion of Wnt5α significantly delayed the promotion of osteogenic differentiation and partially alleviated the inhibitory effect of adipogenic differentiation of BMSCs in the PA28γ-overexpressing group. Furthermore, we demonstrated that PA28γ-knockout mice had an inhibited rate of bone healing in a drill-hole femoral bone defect model in vivo. Therefore, our results confirm the effects of PA28γ on bone formation and bone defect repair, indicating that PA28γ mainly interacts with Wnt5α to activate the Wnt/β-catenin signaling pathway regulating BMSCs differentiation homeostasis. Our results reveal the function of PA28γ in bone diseases and provide a new theoretical basis for expanding the treatment of bone diseases.